NAV3-33, NCT05246280: Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA |
|
|
| Terminated | 3 | 196 | US | TC99m-tilmanocept, tilmanocept, Lymphoseek | Navidea Biopharmaceuticals | Rheumatoid Arthritis | 07/24 | 07/24 | | |
| Recruiting | 2 | 200 | US | Pirfenidone, ESBRIET, matching placebo | Veterans Medical Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), San Diego Veterans Healthcare System, University of California, San Diego, University of California, San Francisco, Genentech, Inc. | Chronic Kidney Disease | 05/24 | 12/24 | | |